LOS ANGELES, July 18, 2024 /PRNewswire/ — Eyenuk, a global artificial intelligence (AI) digital health company and leader in real-world applications for AI Eye Screening™ and AI Predictive Biomarkers™, today announced the appointment …
Eyenuk Appoints Bryan Haardt as Chief Executive Officer Read More »
Eyenuk Names Paul Praino Interim Chief Executive Officer
Company Founder Kaushal Solanki Steps Down as CEO, Remains Strategic Advisor and Board Member
Eyenuk Names Paul Praino Interim Chief Executive Officer Read More »
LOS ANGELES, November 28th, 2023 – Eyenuk, Inc., a leading global digital health company specializing in artificial intelligence (AI), today stands shoulder to shoulder with the National Eye Institute (NEI), …
This clearance expands the label of its flagship product, the EyeArt® AI system, broadening the choice for primary care clinics to screen people with diabetes Company’s FDA clearance also includes …
Leads Expansion of Commercial Team Toward Next Stage of Growth LOS ANGELES – February 16, 2023 – Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in …
Eyenuk Welcomes Paul Praino as Chief Commercial Officer Read More »
The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss LOS ANGELES, January 31, …
Brings Eyenuk’s total funding to over $43 million Funding round led by AXA IM Alts; joined by T&W Medica A/S, Kendall Capital Partners, and others Eyenuk adds three new board …
Academic leaders will review their experience with the technology during a symposium at AAO 2022, the American Academy of Ophthalmology annual meeting CHICAGO, September 30, 2022 — From the American …
Program selects Eyenuk’s EyeArt AI system to make vision-saving screening more accessible in remote Ontario communities LOS ANGELES and TORONTO, August 16, 2022 – Vision Loss Rehabilitation Canada (VLRC), Canada’s …
LOS ANGELES, June 8, 2022 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI …
LOS ANGELES, June 1, 2022 – Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening™ and AI …
Harnessing Artificial Intelligence, Eyenuk is Focused on Improving Population Health Outcomes by Bringing Diabetes Complication Management to Point-of-Care and Community Settings WASHINGTON, March 10, 2022 – Population Health Alliance …
A new diabetic retinopathy screening benefit enabled by the EyeArt® AI system is made available by Discovery Health, a global leader in Healthcare and Financial Services LOS ANGELES, December 7, …
Eyenuk Launches EyeArt AI System in South Africa in Collaboration with Discovery Health Read More »
The published results demonstrate exceptional EyeArt accuracy in a pre-registered, prospective, multicenter clinical trial Los Angeles, November 15, 2021 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and …
The CMS Final Rule establishes a national payment for CPT code 92229 that describes Eyenuk’s FDA-cleared EyeArt® AI system and confirms that AI can be used to close care gaps …
LOS ANGELES, July 26, 2021 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced that …
Financing led by AXA IM’s Impact Investing strategy Los Angeles, CA, July 20, 2021 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader …
Upcoming Webinar Series to Feature Customer Clinical Successes Los Angeles, CA, May 12, 2021 — Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader …
EyeArt is the First FDA Cleared AI Technology for Autonomous Detection of Both More than mild and Vision-Threatening Diabetic Retinopathy Los Angeles, CA, August 5, 2020 — Eyenuk, Inc., a …
Artificial intelligence could help prevent eye damage and sight loss in people with diabetes and save NHS millions of pounds annually MONDAY 6THJULY 2020 Results from the largest study of …
